第 1 到 6 筆結果,共 6 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial | CHIEH-CHANG CHEN ; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; MEI-JYH CHEN ; CHIA-TUNG SHUN ; Liu T.-Y.; YI-CHIA LEE ; Liou§ J.-M.; MING-SHIANG WU ; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Therapeutic Advances in Gastroenterology | 5 | 6 | |
2 | 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; MEI-JYH CHEN ; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; YI-CHIA LEE ; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 18 | 15 | |
3 | 2016 | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN ; Lin J.-T.; YI-CHIA LEE ; MING-SHIANG WU ; the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gut | 63 | 59 | |
4 | 2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 41 | 38 | |
5 | 2015 | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria | YU-JEN FANG ; JYH-MING LIOU ; CHIEH-CHANG CHEN ; Lee J.-Y.; Hsu Y.-C.; MEI-JYH CHEN ; PING-HUEI TSENG ; CHIEN-CHUAN CHEN ; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; HSIU-PO WANG ; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | Gut | 66 | 51 | |
6 | 2013 | Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; YU-JEN FANG ; Lee J.-Y.; CHIEN-CHUAN CHEN ; SHIH-JER HSU ; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG ; Chang L.; Chang W.-H.; HSIU-PO WANG ; CHIA-TUNG SHUN ; Wu J.-Y.; YI-CHIA LEE ; Lin J.-T.; MING-SHIANG WU ; Lin C.-H.; LU-PING CHOW ; TSU-YAO CHENG ; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; CHIH-HSIEN WANG ; Kuo S.-H.; Wu C.-Y. | Journal of Antimicrobial Chemotherapy | 76 | 73 |